Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Ikena Oncology (IKNA) just unveiled an update.
Ikena Oncology, Inc. has elevated Jotin Marango, M.D., Ph.D. to the role of Chief Operating Officer while he retains his positions as Chief Financial Officer and Head of Corporate Development. Dr. Marango brings a wealth of experience from previous high-level roles in biotech firms and equity research, with a strong background in oncology. His promotion includes a salary increase to $470,000 and an option for 400,000 shares, contingent on a strategic company transaction and ongoing service. Dr. Marango’s appointment is based solely on his professional qualifications, with no familial ties to the company’s leadership.
See more insights into IKNA stock on TipRanks’ Stock Analysis page.
